Interestingly, according to GSEA enrichment results, high expression of A2M in ccRCC patients was positively correlated with lymphatic angiogenesis, angiogenesis, VEGF, VEGFR, and other signaling pathways. Here, A2M is linked to nonpapillary renal cell carcinoma.